Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Scientific presentation

Understanding the power of clonal heterogeneity in health and disease

Aaron Viny, MD, MS

Immunohistochemistry (IHC) has been the gold standard to determine if a patient is in remission, but laboratories are transitioning into RT-PCR for fusions and flow cytometry for greater depth of response. However, clinicians are now moving away from algorithms to understand clonal architecture and mutation acquisition and trying their hand at newer technologies, such as single-cell DNA sequencing. Dr. Viny applies single-cell technology to examine clonal hematopoiesis and minimal residual disease (MRD) to better understand why some mutations are chemosensitive and others resistant to therapy.


Scientific presentation
Confidently Validate Cancer Models for Precision Medicine
Dr. Robert Bowman
Divya Rao
Scientific presentation
Unveiling Cellular Complexity: Why & How to Integrate Single-Cell DNA Multi-omics
Brittany Enzmann, PhD
Divya Rao, PhD
Adam Sciambi, PhD
Scientific presentation
Unleashing the Potential of CRISPR & Navigating Heterogeneity in Genome Editing Outcomes
Travis Hardcastle, Synthego
Brittany Enzmann, Mission Bio
Scientific presentation
From Cells to Cures: Panel Discussion on Advancing Clonal Profiling in Leukemia & Myeloma With Single-Cell Multiomics
Hervé Avet-Loiseau, MD, PhD
Felipe Prósper, MD, PhD
Cedric Dos Santos, PhD
Todd Druley, MD, PhD